Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation

NCT05511779 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped Due to delays in enrollment

Conditions

BK Virus Infection
Nephropathy
Kidney Transplantation

Interventions

DRUG: Brincidofovir

Sponsor

SymBio Pharmaceuticals